Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Canmab 150 mg Injection:
Canmab 150 mg Injection is utilized in the treatment of breast and stomach cancer. It operates by targeting and inhibiting the growth of cancer cells through the suppression of HER2 (human epidermal growth factor receptor protein).
Administered as an infusion by a certified medical professional, your physician will determine the necessary dosage and frequency of administration based on your condition, which may change over time. It is crucial to adhere to your physician's instructions precisely to avoid potential adverse effects. The benefits of Canmab 150 mg Injection may take weeks or months to manifest, so it is essential not to discontinue the treatment unless advised by your physician.
Uses of Canmab 150 mg Injection:
Breast cancer
Stomach cancer
Benefits of Canmab 150 mg Injection:
In Breast cancer:
Canmab 150 mg Injection is utilized to treat breast cancer when other medications have failed to demonstrate significant improvement. It helps halt cancer growth and further spread, alleviating symptoms associated with breast cancer such as breast lumps, abnormal nipple discharge, or changes in breast shape or texture. This medication is administered as an infusion by a specialist or nurse.
In Stomach cancer:
Canmab 150 mg Injection assists in eliminating cancer cells and also halts their further growth and spread. Patients are advised to adhere to their doctor's instructions carefully to obtain the most benefit.
Mechanism of action of Canmab 150 mg Injection:
Canmab 150 mg Injection is a recombinant IgG1 monoclonal antibody. It targets the HER2 receptors, which are responsible for the over-proliferation of cancer cells in breast cancer and stomach cancer cells. By inhibiting HER2, it destroys the cancer cells. It also inhibits other cancer-causing downstream signaling pathways.